Candesic provided commercial due diligence to Ampersand Capital Partners
29 November 2023Congratulations to the Ampersand Capital Partners team on their investment in Julius Clinical Research! Candesic provided commercial due diligence to Ampersand Capital Partners. Julius Clinical is a leading…Candesic provided commercial due diligence to NorthEdge
21 November 2023Congratulations to NorthEdge on their acquisition of Torbay Pharmaceuticals. Candesic provided commercial due diligence to NorthEdge. Torbay Pharmaceuticals is a fast growing specialist sterile injectable contract manufacturer. The…Candesic is pleased to have provided commercial due diligence to Mayden
8 November 2023Candesic is pleased to have provided commercial due diligence to Mayden, the leading electronic health record (EHR) for psychological therapies in the…Candesic advised Gyrus Capital on its acquisition of LRE Medical
29 September 2023Gyrus Capital acquired LRE Medical, a provider of high-quality engineering solutions and manufacturing for medical equipment and life science diagnostics.…Candesic is proud to have provided vendor commercial due diligence to Circle Health
11 September 2023Circle Health Group, the largest UK independent hospital operator, is to be sold for ca £1bn to PureHealth, the largest integrated…Our team had the privilege of advising Gresham House Ventures on the investment into Mable Therapy
10 August 2023Our team had the privilege of advising Gresham House Ventures on the investment into Mable Therapy. Mable Therapy is the…Candesic advised IK Partners on the recent acquisition of Medica Group
11 July 2023We are pleased to announce our support to IK Partners in the recently completed acquisition of Medica Group for £271…Candesic proudly advised on Kester Capital investment
21 March 2023Candesic proudly advised on Kester Capital fifth investment in the life sciences sector into MAP Patient Access Limited, a specialist…Candesic supported the deal of DrDoctor by YFM, Ananda and 24Haymarket
10 March 2023We would like to congratulate DrDoctor on the £10m investment from YFM Equity Partners alongside Ananda Impact Ventures and 24Haymarket.…Candesic advised on the acquisition and investment of Aesthetic Technology by Omni Partners
8 March 2023Candesic advised on the acquisition and investment of Aesthetic Technology Ltd by Omni Partners LLP. We are proud to share…
